[1] World Health Organization.Comprehensive cervical cancer control—a guide to essential practice[C].Australia,2006:3-11,127-146.
[2] 余秀华,施红,李黎,等.经阴道彩色多普勒超声诊断宫颈病变的价值[J].中国医学影像学杂志,2006,14(1):4-7.
[3] 吴钟瑜.实用经阴道超声诊断学[M].天津:天津科技翻译出版公司,2008:140.
[4] 乐杰.妇产科学[M].7版.北京:人民卫生出版社,2008:261-268.
[5] 常才.经阴道超声诊断学[M].2版.北京:科学出版社,2007:37.
[6] SONG S H,HONG J H,KWAK S H,et al.Clinical performance assessment of five human papillomavirus DNA tests using liquid-based cytology samples[J].J Obstet Gynaecol Res,2011,19(10):101-103.
[7] GOK M,HEIDEMAN D A,van KEMENADE F J,et al.Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme:characteristics of the responders[J].Eur J Cancer,2011,48(12):1799-1808.
[8] ALCAZAR J L,CASTILLO G,MARTINEX-MONGE R,et al.Transvaginal color Doppler sonography for predicting response to concurrent chemoradiotherapy for locally advanced cervical carcinoma[J].J Clin Ultrasound,2004,32(6):267-272.
[9] AUE-AUNGKUL A,PUNYAWATANASIN S,NATPRATHAN A,et al."See and Treat"approach is appropriate in women with high-grade lesions on either cervical cytology or colposcopy[J].Asian Pac J Cancer Prev,2011,12(7):1723-1726.
[10] 陈年芳.Ⅰb2—Ⅱb期宫颈腺癌患者术前新辅助化疗的疗效观察[J].现代医学,2012,40(5):562-565.
[11] 黄晓明,强健颖,林鹏生.探讨经会阴部超声检查对宫颈机能不全的诊断价值[J].医学影像,2009,47(32) :92-93. |